Incidence and risk factors for intravenous immunoglobulin‐related hemolysis: A systematic review of clinical trial and real‐world populations
H Cuesta, I El Menyawi, A Hubsch, L Hoefferer… - …, 2022 - Wiley Online Library
Background Severe hemolysis rarely occurs in patients receiving intravenous
immunoglobulin (IVIG) therapy. A systematic review was performed to assess the incidence …
immunoglobulin (IVIG) therapy. A systematic review was performed to assess the incidence …
Intravenous immunoglobulin treatment patterns and outcomes in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a US claims database …
C Anderson-Smits, ME Ritchey, Z Huang… - Neurology and …, 2023 - Springer
Introduction Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare
progressive or relapsing inflammatory disease. Intravenous immunoglobulin (IVIG) is …
progressive or relapsing inflammatory disease. Intravenous immunoglobulin (IVIG) is …
Anti‐a/B isoagglutinin reduction in an intravenous immunoglobulin product and risk of hemolytic anemia: a hospital‐based cohort study
C Wallenhorst, A Patel, A Shebl, A Hubsch… - …, 2020 - Wiley Online Library
ABSTRACT BACKGROUND Intravenous immunoglobulins (IVIG) are derived from large
human plasma pools. IVIG‐associated hemolytic anemia (HA) is a known class effect, likely …
human plasma pools. IVIG‐associated hemolytic anemia (HA) is a known class effect, likely …
Isoagglutinin reduction in intravenous immunoglobulin (IgPro10, Privigen) by specific immunoaffinity chromatography reduces its reporting rates of hemolytic reactions …
A Shebl, S Gabriel, K Van Dinther, A Hubsch… - …, 2020 - Wiley Online Library
BACKGROUND Hemolysis is an infrequent but recognized and potentially serious adverse
effect of intravenous immunoglobulin (IVIG). Relatively elevated hemolysis reporting rates …
effect of intravenous immunoglobulin (IVIG). Relatively elevated hemolysis reporting rates …
Hepatitis B virus-associated cryoglobulinaemia diffuse endocapillary proliferative glomerulonephritis: a case report and literature review
W Xu, Y Han - Journal of International Medical Research, 2022 - journals.sagepub.com
Cryoglobulinaemia can manifest as fatigue, purpura, and joint pain, and can involve the
kidneys and peripheral nervous system. Type II and mixed cryoglobulinemia cases are …
kidneys and peripheral nervous system. Type II and mixed cryoglobulinemia cases are …
[HTML][HTML] An optimized microplate-based method to evaluate complement-dependent hemolysis mediated by intravenous immunoglobulins (IVIG)
Y Wang, A Khalenkov, DE Scott - Biologicals, 2022 - Elsevier
Hemolytic reactions can cause serious complications after administration of Intravenous
Immunoglobulin (IVIG), due to passive transfer of anti-A and anti-B IgG antibodies …
Immunoglobulin (IVIG), due to passive transfer of anti-A and anti-B IgG antibodies …
Isoagglutinin‐reduced immunoglobulin retains efficacy in mouse models of immune thrombocytopenia and rheumatoid arthritis and is less likely to cause intravenous …
SY Cen, DR Branch - Transfusion, 2020 - Wiley Online Library
BACKGROUND Immunoglobulin therapy including intravenous immunoglobulin (IVIg) has
been used as an effective treatment for autoimmune/inflammatory conditions with few side …
been used as an effective treatment for autoimmune/inflammatory conditions with few side …
Blood, blood components, plasma, and plasma products
SC Choi, M Casias, D Tompkins, J Gonzalez… - Side Effects of Drugs …, 2019 - Elsevier
This review of 2018 publications identifies side effects of blood, blood components, and
plasma products. In addition, albumin, blood transfusion (erythrocytes, granulocytes, and …
plasma products. In addition, albumin, blood transfusion (erythrocytes, granulocytes, and …
[引用][C] Two roads diverged: Emerging lessons from IVIG about hemolysis
M Asif, B Khor - Transfusion, 2021 - Wiley Online Library
See article on page 1053–1063, in this issue
[引用][C] IVIg and hemolytic anemia risk: dump the anti‐A/B already!
K Yazdanbakhsh, H Zhong - Transfusion, 2020 - Wiley Online Library
See article on page 1381–1390, in this issue